| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/27/2003 | WO2003016466A2 ANTI-Aβ ANTIBODIES |
| 02/27/2003 | WO2003016354A2 Recombinant anti-plasmodium falciparum antibodies |
| 02/27/2003 | WO2003016340A1 Derp1 and proderp1 allergen derivatives |
| 02/27/2003 | WO2003016333A2 Virus coat protein/receptor chimeras and methods of use |
| 02/27/2003 | WO2003015850A1 Method for inducing selectively suppressed immune response |
| 02/27/2003 | WO2003015819A1 Complement pathway inhibitors binding to c5 and c5a without preventing formation of c5b |
| 02/27/2003 | WO2003015813A2 Anti-tumor vaccines |
| 02/27/2003 | WO2003015812A2 Beta-amyloid-analogue-t-cell epitop vaccine |
| 02/27/2003 | WO2003015803A1 Cell compositions for use in the treatment of osteo-arthrosis, and method for producing the same |
| 02/27/2003 | WO2003015800A1 Tissue implants and methods for making and using same |
| 02/27/2003 | WO2003015714A2 Compositions and therapeutic methods for viral infection |
| 02/27/2003 | WO2003015711A2 Combination motif immune stimulatory oligonucleotides with improved activity |
| 02/27/2003 | WO2003015708A2 Composition and method for treating hiv infection |
| 02/27/2003 | WO2003015705A2 In situ immunization |
| 02/27/2003 | WO2003015612A2 Materials and methods to promote repair of nerve tissue |
| 02/27/2003 | WO2003015506A1 Propagation of human hepatoblastoma cell in non-human animals |
| 02/27/2003 | WO2003000656A3 Antisense modulation of transforming growth factor beta receptor ii expression |
| 02/27/2003 | WO2002102989A3 Method for neural stem cell differentiation using valproate |
| 02/27/2003 | WO2002102988A3 Method for neural stem cell differentiation using 5ht-1a agonists |
| 02/27/2003 | WO2002102986A3 Novel human transporter proteins and polynucleotides encoding the same |
| 02/27/2003 | WO2002101052A3 Salutaridinol 7-o-acetyltransferase and derivatives thereof |
| 02/27/2003 | WO2002100348A3 Human monoclonal antibodies to epidermal growth factor receptor (egfr) |
| 02/27/2003 | WO2002099100A3 Method of production of a protein in cells which inducibly express the cell cycle inhibitor protein, p21 |
| 02/27/2003 | WO2002098278A3 Peripheral blood fibrocytes differentiation pathway and migration to wound sites |
| 02/27/2003 | WO2002097046A3 B7 related protein-2 molecules and uses thereof |
| 02/27/2003 | WO2002094853A3 Antibodies specific for poly(ethylene glycol) |
| 02/27/2003 | WO2002094005A3 The use of drupes as a soil amendment to control nematodes |
| 02/27/2003 | WO2002092134A8 Lentiviral vectors encoding clotting factors for gene therapy |
| 02/27/2003 | WO2002089746A3 Hematopoietic stem cell chimerism to treat autoimmune disease |
| 02/27/2003 | WO2002087511A3 Modulators of elastase inhibitor secretion |
| 02/27/2003 | WO2002086083A3 Methods of enhancing cell responsiveness |
| 02/27/2003 | WO2002083864A3 Methods and reagents for cell transplantation |
| 02/27/2003 | WO2002080851A3 Chimeric vaccines |
| 02/27/2003 | WO2002080845A3 Novel eps8 compounds for therapy and diagnosis and methods for using same |
| 02/27/2003 | WO2002080844A3 Novel bgp compounds for therapy and diagnosis and methods for using same |
| 02/27/2003 | WO2002067867A3 Rapid preparation of stem cell matrices for use in tissue and organ treatment and repair |
| 02/27/2003 | WO2002067669A3 Primordial germ cell-based germ line production of birds |
| 02/27/2003 | WO2002064754B1 Medium for culturing tumour cells |
| 02/27/2003 | WO2002055725A3 Novel nucleic acids, methods and transformed cells for the modulation of gibberellin production |
| 02/27/2003 | WO2002055555A3 Antigenic ck-18 compounds for therapy and diagnosis and methods for using same |
| 02/27/2003 | WO2002048375A3 Purified active hcv ns2/3 protease |
| 02/27/2003 | WO2002044336A3 Method of making a protein polymer and uses of the polymer |
| 02/27/2003 | WO2002042451A3 Aspergillus fumigatus cofilin |
| 02/27/2003 | WO2002042436A3 Isolated human phosphatase proteins, nucleic acid molecules encoding them, and uses thereof |
| 02/27/2003 | WO2002032378A3 Fusion cells and cytokine compositions for treatment of disease |
| 02/27/2003 | WO2002031156A3 Bvh-a2 and bvh-a3 antigens of group b streptococcus |
| 02/27/2003 | WO2002020767A3 G-csf analog compositions and methods |
| 02/27/2003 | WO2002018607A3 Transgenic plants containing molecular decoys that alter protein content therein |
| 02/27/2003 | WO2002016548A8 Novel g protein-coupled receptor |
| 02/27/2003 | WO2002012290A8 Sid polypeptides binding to pathogenic strain of the hepatitis c virus |
| 02/27/2003 | WO2002010352A3 Production of human monoclonal antibodies |
| 02/27/2003 | WO2002009644A3 Angiogenic and osteogenic proteins for use in enhancing bone density and formation |
| 02/27/2003 | WO2002008441A8 Process for producing non-cellulosic callose fiber by plant protoplast and callose fiber |
| 02/27/2003 | WO2002008269A3 A cytochrome p450 enzyme associated with the synthesis of δ12-epoxy groups in fatty acids of plants |
| 02/27/2003 | WO2002008267A3 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 02/27/2003 | WO2002006308A3 Methods for promoting dendritic cell proliferation or differentiation |
| 02/27/2003 | WO2002004605A3 Stimulation of cellular regeneration and differentiation in the inner ear |
| 02/27/2003 | WO2002004022A8 High fidelity polymerases and uses thereof |
| 02/27/2003 | WO2002002797A3 Regulation of human 11 beta-hydroxysteroid dehydrogenase 1-like enzyme |
| 02/27/2003 | WO2002001950A3 Transgenic mice containing targeted gene disruptions |
| 02/27/2003 | WO2002000691A3 Polynucleotides and polypeptides encoded thereby |
| 02/27/2003 | WO2001098481A3 Renal regulatory elements and methods of use thereof |
| 02/27/2003 | WO2001098471A3 Human phosphodiesterases |
| 02/27/2003 | WO2001075164A3 Rna sequence-specific mediators of rna interference |
| 02/27/2003 | US20030041345 Nucleotide sequences coding enzymatic polypeptide for use in the propagation of plants |
| 02/27/2003 | US20030041344 Receptor kinase, BIN1 |
| 02/27/2003 | US20030041341 Non-human transgenic animal whose germ cells and somatic cells contain a knockout mutation in DNA encoding 4E-BP1 |
| 02/27/2003 | US20030041337 Animal model for use in the diagnosis and treatment of diabetic phenotype |
| 02/27/2003 | US20030040617 For detecting, prophylaxis and therapy of disorders of the colon and/or rectum, including, but not limited to, the presence of colorectal cancer and colorectal cancer metastases |
| 02/27/2003 | US20030040609 Isolation of inositol from carob extracts; obtain carob, expose to chhromatographic column, recover inositol |
| 02/27/2003 | US20030040607 Hematopoietic cell E-selection/L-selectin ligand polypeptides and methods of use thereof |
| 02/27/2003 | US20030040603 Purified mammalian CTLA-8 antigens and related reagents |
| 02/27/2003 | US20030040481 Contacting a tissue factor(TF)-expressing cell with a motility modifying-effective amount of a compound selected from the group consisting of Factor VIIa; a Factor VIIa agonist; and a Factor VIIa antagonist for modifying cell motility |
| 02/27/2003 | US20030040473 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/27/2003 | US20030040462 Spraying into a hot gas stream an aqueous mixture of the material and a carrier substance which is water-soluble or water-swellable, thereby drying the mixture to particles which contain the material and the carrier substance |
| 02/27/2003 | US20030040461 Providing a cell expressing Bruton's Tyrosine Kinase; contacting cell expressing Bruton's Tyrosine Kinase with a test compound; determining whether test compound modulates the activity of Bruton's Tyrosine Kinase |
| 02/27/2003 | US20030040113 Propagation of cell tissue in suspension; prepare solution of chondrocytes, expose to sponge matrix, solidify matrix, recover solid support |
| 02/27/2003 | US20030040112 Materials and methods for nerve grafting, selection of nerve grafts, and in vitro nerve tissue culture |
| 02/27/2003 | US20030040111 Differentiated cells suitable for human therapy |
| 02/27/2003 | US20030040110 Human mullerian duct-derived epithelial cells and methods of isolation and uses thereof |
| 02/27/2003 | US20030040101 Transgenic cell for in the generation and propagation of viral expression vectors |
| 02/27/2003 | US20030040100 Cell for the propagation of adenoviral vectors |
| 02/27/2003 | US20030040098 Glutaminase, glutaminase gene, novel recombinant DNA, and process for manufacturing glutaminase |
| 02/27/2003 | US20030040096 Nucleotide sequences coding enzmatic polypeptide for use in the treatment of acquired immunodeficiency syndromes, nervous system and ischemic injury disorders |
| 02/27/2003 | US20030040093 Platelet activating factor acetylhydrolase, and gene thereof |
| 02/27/2003 | US20030040083 Dual specificity antibodies and methods of making and using |
| 02/27/2003 | US20030040080 Sensitizing cells to light; obtain cells, transform with vector containing preferential proteins, expose to retinal, illuminate, monitor cell response |
| 02/27/2003 | US20030040079 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative and tumor disorders |
| 02/27/2003 | US20030040078 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative and tumor disorders |
| 02/27/2003 | US20030040076 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/27/2003 | US20030040071 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative and tumor disorders |
| 02/27/2003 | US20030040054 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/27/2003 | US20030040053 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cell proliferative disorders and tumors |
| 02/27/2003 | US20030040052 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of human cancers |
| 02/27/2003 | US20030040048 Nucleotide sequences coding polypeptide for use in the treatment of cancer, heart and viral diseases |
| 02/27/2003 | US20030040046 Netrin receptors |
| 02/27/2003 | US20030040045 Mammalian sweet taste receptors |
| 02/27/2003 | US20030040044 Anti-dual integrin antibodies, compositions, methods and uses |
| 02/27/2003 | US20030040039 Nucleotide sequences coding polypeptide for use in the treatment of diabetes |
| 02/27/2003 | US20030040038 Screening effect of modulators on target cells; obtain cell, transform with expresion vector coding activator and preferential protein, monitor cell activity, compare to control |